Emerging therapies for hepatitis C and HIV in drug abusers: drugs and strategies. - Wikidata - wikimedia - TriplyDB

Emerging therapies for hepatitis C and HIV in drug abusers: drugs and strategies.

Emerging therapies for hepatitis C and HIV in drug abusers: drugs and strategies.

http://www.wikidata.org/entity/Q37235541

about

Clinical management of drug addicts infected with human immunodeficiency virus and hepatitis C virus.

P2860

Q37235521-E4121D12-CF9F-4FD1-801E-D3D8926FFC3D

P2860

Emerging therapies for hepatitis C and HIV in drug abusers: drugs and strategies.

http://www.wikidata.org/entity/Q37235541

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Emerging therapies for hepatitis C and HIV in drug abusers: drugs and strategies.

@en

Emerging therapies for hepatitis C and HIV in drug abusers: drugs and strategies.

@nl

type

label

Emerging therapies for hepatitis C and HIV in drug abusers: drugs and strategies.

@en

Emerging therapies for hepatitis C and HIV in drug abusers: drugs and strategies.

@nl

prefLabel

Emerging therapies for hepatitis C and HIV in drug abusers: drugs and strategies.

@en

Emerging therapies for hepatitis C and HIV in drug abusers: drugs and strategies.

@nl

P1433

Q37235541-A0627154-28AA-4F10-A966-3E375FD13586

P1476

Q37235541-454EE696-6BAA-4C55-BC1E-692DEE563A24

P2093

Q37235541-11AD39A2-3396-4355-A3A0-6C30D1A2B982

P2860

Q37235541-04F1A3A8-1F1B-473A-AB00-3A7066D296EE

Q37235541-0880AD4C-59DA-48A1-ADF3-9681F54D61A4

Q37235541-202F7C0F-92AB-43F4-BD22-ED1F7CCA90EB

Q37235541-24B5163D-8EBE-455D-A1C8-E541F69AF3FA

Q37235541-2BC1EA29-3BFB-4F44-BA2D-09D8EA087EBA

Q37235541-56A39B9C-94EB-4FA8-8A2E-6566A9CE8101

Q37235541-5958F879-9D11-46AB-B185-2E708D56B2BE

Q37235541-61334711-EEAA-48BC-9343-AA2B1020D571

Q37235541-6871D14C-F41E-4154-806C-447B14997081

Q37235541-6FB292DA-C0E0-4C91-9D8E-BF6CF2FF351B

P304

Q37235541-4974DCA0-E2A7-4A4C-A245-BDB5A73319A0

P31

Q37235541-967885C2-61BC-4F8D-8CEC-862F6540834B

P356

Q37235541-0345F206-396F-4FAC-A87A-CCEF7F47CF1A

P433

Q37235541-24FCDD61-6EF9-4891-A08C-14061EDC7C23

P478

Q37235541-4E67BDEF-96EE-488A-9F57-99394906F53D

P577

Q37235541-3413FB06-D59C-480D-B0F8-CCFDEC915D2D

P698

Q37235541-3044B041-1353-4F68-B1A0-626AAF77FA05

P356

P1433

Journal of Addictive Diseases

P1476

Emerging therapies for hepatitis C and HIV in drug abusers: drugs and strategies.

@en

P2093

Ellen M Tedaldi

http://www.w3.org/2001/XMLSchema#string

P2860

Small interfering RNA targeted to stem-loop II of the 5' untranslated region effectively inhibits expression of six HCV genotypes

Hepatitis C Virus Replication in Transfected and Serum-Infected Cultured Human Fetal Hepatocytes

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons

Treating HCV with ribavirin analogues and ribavirin-like molecules

Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial

P304

83-91

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1300/J069V27N02_10

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18681195

http://www.w3.org/2001/XMLSchema#string